글로벌 심장판막질환 치료 시장 - 2029년까지의 산업 동향 및 예측

시장 분석 및 통찰력 글로벌 심장판막 질환 치료 시장

심장판막 질환 치료 시장은 2022-2029년 예측 기간에 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간에 시장이 12.1%의 CAGR로 성장할 것으로 분석했습니다. 시장 가치의 이러한 상승은 노령 인구의 증가와 건강에 해로운 생활 방식의 채택 증가에 기인할 수 있습니다.

심장판막 질환은 판막 심장 질환이라고도 하며, 심장 판막의 기능 장애입니다. 판막 협착증이나 판막 기능 부전으로 인해 발생할 수 있습니다. 어떤 경우에는 판막 중 하나 이상이 제대로 기능하지 못해 몸 전체의 혈류가 중단됩니다. 증상으로는 비정상적인 심음(잡음), 호흡 곤란, 피로, 발목과 발 부기, 현기증, 실신 등이 있습니다.

2022-2029년 예측 기간에는 심장판막 질환 치료를 위한 새롭고 혁신적인 연구개발이 심장판막 질환 치료 시장의 성장을 가속화할 가능성이 가장 높습니다. 반면, 안과 수술 기술의 발전과 제약 회사의 연구개발 투자는 다양한 기회를 더욱 촉진하여 예측 기간 동안 심장판막 질환의 성장으로 이어질 것입니다.

침습적 심장학은 빠르게 진화하고 있으며, 심장 수술에 최소 침습적 기술을 사용하면서 시장 성장이 가속화되고 있습니다. 판막 교체 및 성인 심장 수술(예: 판막 심장 질환 치료)에 대한 연구 개발이 증가하면서 예측 기간 동안 시장 성장이 촉진될 것입니다. 개발도상국의 의료 인프라 확장으로 인해 심장 판막 질환 치료 시장이 활성화되고 있습니다.

However, the market is hampered by the high cost of diagnostics and surgeries. In the near future, market growth will be hampered by stringent government regulations and medical authorities. The market's growth is being hampered by a scarcity of experts and medical practitioners for heart surgery.

This heart valve disease treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the heart valve disease treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Heart Valve Disease Treatment Market Scope and Market Size

Heart valve disease treatment market is segmented on the basis of types, treatment, drugs class, route of administration, distribution channel and end-users. The growth among these specific segments will help users analyze niche pockets of growth and strategies to approach the market and determine your core application areas and difference in your target markets.

• Based on treatment, the heart valve disease treatment market is segmented into medication and surgery.
• Based on types, the heart valve disease treatment market is segmented into valvular stenosis and valvular insufficiency.
• Based on drugs class, the heart valve disease treatment market is segmented diuretics, anti-arrhythmic agents, vasodilators, angiotensin-converting enzyme (ACE) inhibitors, beta blockers, anticoagulants and others.
• Based on the route of administration, the heart valve disease treatment market is segmented into oral, intravenous and others.
• Based on the distribution channel, the heart valve disease treatment market is segmented as hospital pharmacy, online pharmacy and retail pharmacy.
• Based on end-users, the heart valve disease treatment market is segmented into hospitals, homecare, specialty clinics and others.

Heart Valve Disease Treatment Market Country Level Analysis

Diabetic macular heart valve disease treatment market is analysed and market size information is provided by the country, types, treatment, drugs class, route of administration, distribution channel and end-users as referenced above.

The countries covered in the heart valve disease treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the heart valve disease treatment market due to the increasing prevalence of cardiac diseases, the high adoption rates of cardiac devices, and the presence of a well-established healthcare sector are all factors to consider. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing geriatric population, a changing lifestyle, and an increase in medical tourism. Asia-Pacific countries are adopting advanced treatment options, which are fuelling market growth in this region. Furthermore, countries such as China, India, and Japan are expected to drive regional market growth.

The country section of the heart valve disease treatment market report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Heart valve disease treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the heart valve disease treatment market report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the heart valve disease treatment market in the growth period.

Competitive Landscape and Heart Valve Disease Treatment Market Share Analysis

심장판막 질환 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 임상 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선입니다. 위에 제공된 데이터 포인트는 심장판막 질환 치료 시장 조사와 관련된 회사의 초점에만 관련이 있습니다.

심장판막 질환 치료 시장의 주요 기업으로는 Abbott, Pfizer Inc., Eli Lilly and Company, AstraZeneca, F. Hoffmann-La Roche Ltd, Bayer AG, Medtronic, Johnson & Johnson Services, Inc, Boehringer Ingelheim International GmbH, CSL Limited, CryoLife, Inc, Mardil Medical, Inc, NeoChord, Inc, Edwards Lifesciences Corporation, SYNECOR, Foldex, Inc, LivaNova PLC, Novosense AB, Servier, Cook 등이 있습니다.

SKU-50499